When was MiLaboratories founded?

MiLaboratories was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is MiLaboratories located?

MiLaboratories is headquartered in San Francisco, United States.

Who is the current CEO of MiLaboratories?

Stanislav Poslavsky of MiLaboratories. They have also founded 3 companies.

How many employees does MiLaboratories have?

As of Jul 31, 2026, the latest employee count at MiLaboratories is 25.

Is MiLaboratories a funded company?

MiLaboratories is a funded company, having raised a total of $12.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of MiLaboratories?

MiLaboratories' latest funding was a $***** Series A round on Oct 10, 2024, with participation from 7 investors.

Where does MiLaboratories rank among its competitors?

MiLaboratories ranks 29th amongst 397 active competitors, of which 76 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was OutSee, which secured $3.36M in Jan, 2026.

Who are the top competitors of MiLaboratories?

MiLaboratories' top competitors include Hexagon Bio, Deep Genomics and BC Platforms. Among them, OutSee secured the most recent funding round in January, 2026.

MiLaboratories - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a software platform for immune repertoire profiling. It provides software for analysis of next-generation sequencing data for immune profiling. It also, offers kits, reagents and MiXCR for immune system studies in academia and industry.

Website: milaboratories.com
Social
Email ID: *****@milaboratories.com
Phone Number: +1 **********

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series A

Total Funding

$12.5M in 3 rounds

Latest Funding Round

Series A, Oct 10, 2024, $*****

Investors

K Fund & 6 more

Ranked

29^th among 397 active competitors

Employee Count

25 as on Jul 31, 2026

Similar Companies

Hexagon Bio & 544 more

View MiLaboratories' full profile

MiLaboratories is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MiLaboratories Inc. CIN: 1910574 , United States, Active		$1 - $1M (As on Feb 17, 2022)	-	-

MiLaboratories has raised a total funding of $12.5M over 3 rounds. Its first funding round was on 2021. Its latest funding round was a Series A round on Oct 10, 2024 for $*****. 7 investors participated in its latest round. MiLaboratories has 7 institutional investors.

Here is the list of recent funding rounds of MiLaboratories:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 10, 2024	3160089	Series A	1199847	3726981	2308536	2432520
2022	1115	Seed	7134	4868	9637	7690
2021	2017	Seed	1847	4344	7020	5415

Access funding benchmarks and valuations. Sign up today!

View details of MiLaboratories's funding rounds and investors

The founders of MiLaboratories is Stanislav Poslavsky. Stanislav Poslavsky is the CEO of MiLaboratories.

Here are the details of MiLaboratories' key team members:

Stanislav Poslavsky: Co-Founder & CEO of MiLaboratories and founder of 2 other companies, MiXCR and Platforma.bio.
Contact Info: 3 email addresses

View details of MiLaboratories's Founder profiles and Board Members

MiLaboratories' employee count trend

MiLaboratories has 25 employees as of Jul 26. Here is MiLaboratories's employee count trend over the years:

Uncover MiLaboratories' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MiLaboratories include Hexagon Bio, Deep Genomics and BC Platforms. Here is the list of Top 10 competitors of MiLaboratories, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	Nextech Invest, The Column Group & 10 others	62/100
2nd	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
3rd	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Jolt Capital, Debiopharm & 6 others	58/100
4th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Omnes Capital & 7 others	57/100
5th	Broken String Biosciences 2020, Cambridge (United Kingdom), Series A	Developer of biopharmaceutical products & cell therapies by using genome sequencing data	$15M	Illumina Ventures, Illumina & 14 others	55/100
6th	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	55/100
7th	OutSee United Kingdom, Seed	Developer of an artificial intelligence engine for predictive genomics	$5.79M	Ahren, Panacea Venture & 2 others	54/100
8th	Zetta Genomics 2018, Worcester (United Kingdom), Seed	Provider of genomic data analysis software for clinical labs & research organizations	$10.4M	Nina Capital, APEX Ventures & 11 others	54/100
9th	Molcure 2013, Tokyo (Japan), Series C	Provider of AI-based platform for drug discovery and design	$11.7M	JAFCO Group, Dai-Ichi Life & 7 others	53/100
10th	Active Motif 1999, Carlsbad (United States), Funding Raised	Provider of research kits, assays and biocomputing systems	-	National Science Foundation, Broadoak Capital Partners ... & 1 others	52/100
29th	MiLaboratories 2021, San Francisco (United States), Series A	Provider of a software platform for immune repertoire profiling	$12.5M	Speedinvest, Acrobator & 5 others	42/100